Determinants of the Recommended Phase 2 Dose of Molecular Targeted Agents
Cancer - United States
doi 10.1002/cncr.30579
Full Text
Open PDFAbstract
Available in full text
Date
February 9, 2017
Authors
Publisher
Wiley
Available in full text
February 9, 2017
Wiley